Track the Atrys Health, S.A. share price and the full directors' dealings record of the company, a listed issuer based in Spain. Shares trade on the ES market, under the oversight of CNMV. Operating in the Healthcare & Pharma sector, Atrys Health, S.A. has recorded 81 public disclosures. Market capitalisation: €179.9m. The latest transaction was disclosed on 9 July 2026 (Purchase). Among the most active insiders: Santiago de Torres Sanahuja. The full history is openly available.
81
Insider Decl.
n/a
Thresholds
€12m
62 ops.
Buy Volume
€28m
14 ops.
Sell Volume
37Σ signal
Buys €12m€28m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,931 of 29,024 companies
18.6
score / 100
Value
12
Quality
25
FCF yld-7.3%
Earn yld-52%
EV/EBITDA·
ROE-27%
Gross mgn44%
Net mgn-71%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,000 shares@ €3.920.0019% mcap17.0% of flowShareXMADISINISIN ES0105148003CNMV:2023136120
25 of 81 declarations
About Atrys Health, S.A.
ATRYS HEALTH, S.A. is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for the diagnosis and treatment of diseases. It is listed on the XMAD market.